[
  {
    "model": "survey.survey",
    "pk": 9,
    "fields": {
      "name": "The Rapid Progressor with ADPKD",
      "slug": "rapid-progressor-adpkd",
      "therapeutic_area": 2,
      "active": true,
      "created_at": "2018-01-09T10:04:31.171Z",
      "start": "2018-01-09T09:53:15Z",
      "end": "2018-02-28T00:00:00Z",
      "countries": [
        5,
        7,
        4,
        3
      ],
      "organizations": [
        3,
        4
      ]
    }
  },
  {
    "model": "survey.question",
    "pk": 17,
    "fields": {
      "survey": 9,
      "ordering": 1,
      "type": "type_multiselect_with_other",
      "field": null,
      "text": "How do you determine that a patient is a Fast Progressor?",
      "depends_on": null,
      "available_if": "",
      "dependency_type": null,
      "script": "",
      "created_at": "2018-01-09T10:04:31.201Z"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 1,
    "fields": {
      "question": 17,
      "lang": 1,
      "text": "Wie stellen Sie fest, dass ein Patient ein schneller Progressor ist?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 10,
    "fields": {
      "question": 17,
      "lang": 2,
      "text": "\u00bfC\u00f3mo se determina que un paciente es un Progresor r\u00e1pido?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 11,
    "fields": {
      "question": 17,
      "lang": 3,
      "text": "\u00bfC\u00f3mo se determina que un paciente es un Progresor r\u00e1pido?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 12,
    "fields": {
      "question": 17,
      "lang": 4,
      "text": "\u00bfC\u00f3mo se determina que un paciente es un Progresor r\u00e1pido?"
    }
  },
  {
    "model": "survey.option",
    "pk": 61,
    "fields": {
      "question": 17,
      "value": "ERA-EDTA",
      "ordering": 0,
      "created_at": "2018-01-09T10:04:31.214Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 62,
    "fields": {
      "question": 17,
      "value": "Mayo Clinic",
      "ordering": 1,
      "created_at": "2018-01-09T10:04:31.216Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 63,
    "fields": {
      "question": 17,
      "value": "Country",
      "ordering": 2,
      "created_at": "2018-01-09T10:04:31.217Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 64,
    "fields": {
      "question": 17,
      "value": "Combination",
      "ordering": 3,
      "created_at": "2018-01-09T10:04:31.218Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 65,
    "fields": {
      "question": 17,
      "value": "PRO PKD score",
      "ordering": 4,
      "created_at": "2018-01-09T10:04:31.219Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 66,
    "fields": {
      "question": 17,
      "value": "Hospital\/Centre Guidelines",
      "ordering": 5,
      "created_at": "2018-01-09T10:04:31.221Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 67,
    "fields": {
      "question": 17,
      "value": "Family History",
      "ordering": 6,
      "created_at": "2018-01-09T10:04:31.222Z"
    }
  },
  {
    "model": "reports.representation",
    "pk": 15,
    "fields": {
      "type": "type_multiselect",
      "question": 17,
      "active": true,
      "ordering": 1,
      "label1": "",
      "label2": "",
      "label3": ""
    }
  },
  {
    "model": "survey.question",
    "pk": 18,
    "fields": {
      "survey": 9,
      "ordering": 2,
      "type": "type_simple_input",
      "field": 1,
      "text": "What percentage of your patients do you consider to be fast progressors?",
      "depends_on": null,
      "available_if": "",
      "dependency_type": null,
      "script": "",
      "created_at": "2018-01-09T10:04:31.203Z"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 2,
    "fields": {
      "question": 18,
      "lang": 1,
      "text": "Welchen Prozentsatz Ihrer Patienten halten Sie f\u00fcr einen schnellen Progressor?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 13,
    "fields": {
      "question": 18,
      "lang": 4,
      "text": "What percentage of your patients do you consider to be fast progressors?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 14,
    "fields": {
      "question": 18,
      "lang": 2,
      "text": "\u00bfQu\u00e9 porcentaje de sus pacientes considera que son progresores r\u00e1pidos?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 15,
    "fields": {
      "question": 18,
      "lang": 3,
      "text": "Quel pourcentage de vos patients consid\u00e9rez-vous comme des progresseurs rapides?"
    }
  },
  {
    "model": "reports.representation",
    "pk": 16,
    "fields": {
      "type": "type_average_percent",
      "question": 18,
      "active": true,
      "ordering": 2,
      "label1": "",
      "label2": "",
      "label3": ""
    }
  },
  {
    "model": "survey.question",
    "pk": 19,
    "fields": {
      "survey": 9,
      "ordering": 3,
      "type": "type_simple_input",
      "field": 1,
      "text": "Out of your patients that you consider to be fast progressors, to what percentage of patients are you offering treatment?",
      "depends_on": null,
      "available_if": "",
      "dependency_type": null,
      "script": "",
      "created_at": "2018-01-09T10:04:31.205Z"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 3,
    "fields": {
      "question": 19,
      "lang": 1,
      "text": "Von Ihren Patienten, die Sie als schnelle Progressoren betrachten, zu welchem Prozentsatz von Patienten bieten Sie eine Behandlung an?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 16,
    "fields": {
      "question": 19,
      "lang": 3,
      "text": "Parmi vos patients que vous consid\u00e9rez comme des progresseurs rapides, \u00e0 quel pourcentage de patients offrez-vous un traitement?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 17,
    "fields": {
      "question": 19,
      "lang": 2,
      "text": "De sus pacientes que considera que son progresores r\u00e1pidos, \u00bfa qu\u00e9 porcentaje de pacientes est\u00e1 ofreciendo tratamiento?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 18,
    "fields": {
      "question": 19,
      "lang": 4,
      "text": "Tra i tuoi pazienti che consideri progressisti veloci, a quale percentuale di pazienti stai offrendo un trattamento?"
    }
  },
  {
    "model": "reports.representation",
    "pk": 17,
    "fields": {
      "type": "type_average_percent",
      "question": 19,
      "active": true,
      "ordering": 3,
      "label1": "",
      "label2": "",
      "label3": ""
    }
  },
  {
    "model": "survey.question",
    "pk": 20,
    "fields": {
      "survey": 9,
      "ordering": 4,
      "type": "type_simple_input",
      "field": 1,
      "text": "Of your patients to whom you are offering treatment, what percentage start Tolvaptan?",
      "depends_on": null,
      "available_if": "",
      "dependency_type": null,
      "script": "",
      "created_at": "2018-01-09T10:04:31.206Z"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 4,
    "fields": {
      "question": 20,
      "lang": 1,
      "text": "Von welchen Patienten, f\u00fcr die Sie eine Behandlung anbieten, wie viel Prozent beginnen mit Tolvaptan?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 19,
    "fields": {
      "question": 20,
      "lang": 4,
      "text": "Dei tuoi pazienti ai quali stai offrendo un trattamento, quale percentuale inizia con Tolvaptan?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 20,
    "fields": {
      "question": 20,
      "lang": 3,
      "text": "Parmi vos patients \u00e0 qui vous offrez un traitement, quel pourcentage commence Tolvaptan?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 21,
    "fields": {
      "question": 20,
      "lang": 2,
      "text": "De sus pacientes a los que ofrece tratamiento, \u00bfqu\u00e9 porcentaje comienza con Tolvaptan?"
    }
  },
  {
    "model": "reports.representation",
    "pk": 18,
    "fields": {
      "type": "type_average_percent",
      "question": 20,
      "active": true,
      "ordering": 4,
      "label1": "",
      "label2": "",
      "label3": ""
    }
  },
  {
    "model": "survey.question",
    "pk": 21,
    "fields": {
      "survey": 9,
      "ordering": 5,
      "type": "type_multiselect_ordered",
      "field": null,
      "text": "For patients identified as being at risk of rapid progression, what are your top reasons for NOT starting treatment with Tolvaptan? (aim for top five reasons)",
      "depends_on": null,
      "available_if": "",
      "dependency_type": null,
      "script": "",
      "created_at": "2018-01-09T10:04:31.208Z"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 5,
    "fields": {
      "question": 21,
      "lang": 1,
      "text": "Bei Patienten, bei denen das Risiko einer raschen Progression besteht, was sind Ihre Hauptgr\u00fcnde daf\u00fcr, die Behandlung mit Tolvaptan NICHT zu beginnen? (Ziel f\u00fcr die besten f\u00fcnf Gr\u00fcnde)"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 22,
    "fields": {
      "question": 21,
      "lang": 2,
      "text": "Para los pacientes identificados como en riesgo de progresi\u00f3n r\u00e1pida, \u00bfcu\u00e1les son sus principales razones para NO iniciar el tratamiento con Tolvaptan? (apunte a las cinco razones principales)"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 23,
    "fields": {
      "question": 21,
      "lang": 3,
      "text": "Pour les patients identifi\u00e9s comme \u00e9tant \u00e0 risque de progression rapide, quelles sont vos principales raisons de ne PAS commencer un traitement par Tolvaptan? (viser les cinq meilleures raisons)"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 24,
    "fields": {
      "question": 21,
      "lang": 4,
      "text": "Per i pazienti identificati come a rischio di rapida progressione, quali sono i tuoi principali motivi per NON iniziare il trattamento con Tolvaptan? (obiettivo per i cinque migliori motivi)"
    }
  },
  {
    "model": "survey.option",
    "pk": 68,
    "fields": {
      "question": 21,
      "value": "Believe in the efficacy\/safety",
      "ordering": 1,
      "created_at": "2018-01-09T10:04:31.226Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 69,
    "fields": {
      "question": 21,
      "value": "Patient disagrees",
      "ordering": 2,
      "created_at": "2018-01-09T10:04:31.232Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 70,
    "fields": {
      "question": 21,
      "value": "Reimbursement issues",
      "ordering": 3,
      "created_at": "2018-01-09T10:04:31.233Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 71,
    "fields": {
      "question": 21,
      "value": "Access to the drug",
      "ordering": 4,
      "created_at": "2018-01-09T10:04:31.234Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 72,
    "fields": {
      "question": 21,
      "value": "RMP issues",
      "ordering": 5,
      "created_at": "2018-01-09T10:04:31.235Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 73,
    "fields": {
      "question": 21,
      "value": "Centre capacity\/workload",
      "ordering": 6,
      "created_at": "2018-01-09T10:04:31.236Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 74,
    "fields": {
      "question": 21,
      "value": "Awaiting clinical trial",
      "ordering": 7,
      "created_at": "2018-01-09T10:04:31.237Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 75,
    "fields": {
      "question": 21,
      "value": "Lack of efficacy marker",
      "ordering": 8,
      "created_at": "2018-01-09T10:04:31.238Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 76,
    "fields": {
      "question": 21,
      "value": "No urgency to treat",
      "ordering": 9,
      "created_at": "2018-01-09T10:04:31.239Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 77,
    "fields": {
      "question": 21,
      "value": "Age",
      "ordering": 10,
      "created_at": "2018-01-09T10:04:31.240Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 78,
    "fields": {
      "question": 21,
      "value": "Advanced CKD stage",
      "ordering": 11,
      "created_at": "2018-01-09T10:04:31.241Z"
    }
  },
  {
    "model": "reports.representation",
    "pk": 19,
    "fields": {
      "type": "type_multiselect_top5",
      "question": 21,
      "active": true,
      "ordering": 5,
      "label1": "Label 1",
      "label2": "Label 2",
      "label3": "Label 3"
    }
  },
  {
    "model": "survey.question",
    "pk": 22,
    "fields": {
      "survey": 9,
      "ordering": 6,
      "type": "type_multiselect_ordered",
      "field": null,
      "text": "What are the top three reasons that would make you start a patient on Tolvaptan?",
      "depends_on": null,
      "available_if": "",
      "dependency_type": null,
      "script": "",
      "created_at": "2018-01-12T18:03:45.484Z"
    }
  },
  {
    "model": "survey.question",
    "pk": 23,
    "fields": {
      "survey": 9,
      "ordering": 7,
      "type": "type_multiselect_ordered",
      "field": null,
      "text": "If the main reason to start a patient on Tolvaptan are symptoms, what are they?",
      "depends_on": 22,
      "available_if": "Symptoms",
      "dependency_type": 2,
      "script": "",
      "created_at": "2018-01-12T18:08:00.111Z"
    }
  },
  {
    "model": "survey.question",
    "pk": 24,
    "fields": {
      "survey": 9,
      "ordering": 8,
      "type": "type_multiselect_ordered",
      "field": null,
      "text": "If pain is the main symptom to start a patient on Tolvaptan, what are the pain characteristics?",
      "depends_on": 23,
      "available_if": "Pain",
      "dependency_type": 2,
      "script": "",
      "created_at": "2018-01-12T18:11:07.160Z"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 8,
    "fields": {
      "question": 24,
      "lang": 1,
      "text": "Wenn Schmerz das Hauptsymptom ist, um einen Patienten auf Tolvaptan zu beginnen, was sind die Schmerzmerkmale?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 31,
    "fields": {
      "question": 24,
      "lang": 2,
      "text": "Si el dolor es el s\u00edntoma principal para iniciar a un paciente con Tolvaptan, \u00bfcu\u00e1les son las caracter\u00edsticas del dolor?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 32,
    "fields": {
      "question": 24,
      "lang": 3,
      "text": "Si la douleur est le principal sympt\u00f4me de d\u00e9part d'un patient sous Tolvaptan, quelles sont les caract\u00e9ristiques de la douleur?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 33,
    "fields": {
      "question": 24,
      "lang": 4,
      "text": "Se il dolore \u00e8 il sintomo principale per iniziare un paziente con Tolvaptan, quali sono le caratteristiche del dolore?"
    }
  },
  {
    "model": "survey.option",
    "pk": 93,
    "fields": {
      "question": 24,
      "value": "Acute",
      "ordering": 1,
      "created_at": "2018-01-12T18:11:07.366Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 94,
    "fields": {
      "question": 24,
      "value": "Chronic",
      "ordering": 2,
      "created_at": "2018-01-12T18:11:07.367Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 95,
    "fields": {
      "question": 24,
      "value": "Need to be treated with pharmacological drugs",
      "ordering": 3,
      "created_at": "2018-01-12T18:11:07.368Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 96,
    "fields": {
      "question": 24,
      "value": "Time off work",
      "ordering": 4,
      "created_at": "2018-01-12T18:11:07.369Z"
    }
  },
  {
    "model": "reports.representation",
    "pk": 22,
    "fields": {
      "type": "type_multiselect_top",
      "question": 24,
      "active": true,
      "ordering": 8,
      "label1": "Label1",
      "label2": "Label2",
      "label3": "Label3"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 7,
    "fields": {
      "question": 23,
      "lang": 1,
      "text": "Wenn der Hauptgrund, einen Patienten auf Tolvaptan zu starten, Symptome sind, was sind sie?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 28,
    "fields": {
      "question": 23,
      "lang": 2,
      "text": "Si la raz\u00f3n principal para iniciar a un paciente con Tolvaptan son los s\u00edntomas, \u00bfcu\u00e1les son?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 29,
    "fields": {
      "question": 23,
      "lang": 3,
      "text": "Si la principale raison de commencer un patient sous Tolvaptan sont les sympt\u00f4mes, quels sont-ils?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 30,
    "fields": {
      "question": 23,
      "lang": 4,
      "text": "Se il motivo principale per iniziare un paziente con Tolvaptan sono i sintomi, quali sono?"
    }
  },
  {
    "model": "survey.option",
    "pk": 87,
    "fields": {
      "question": 23,
      "value": "Pain",
      "ordering": 1,
      "created_at": "2018-01-12T18:08:00.264Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 88,
    "fields": {
      "question": 23,
      "value": "Haematuria",
      "ordering": 2,
      "created_at": "2018-01-12T18:08:00.272Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 89,
    "fields": {
      "question": 23,
      "value": "Blood Pressure",
      "ordering": 3,
      "created_at": "2018-01-12T18:08:00.273Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 90,
    "fields": {
      "question": 23,
      "value": "Infections",
      "ordering": 4,
      "created_at": "2018-01-12T18:08:00.274Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 91,
    "fields": {
      "question": 23,
      "value": "Kidney Stones",
      "ordering": 5,
      "created_at": "2018-01-12T18:08:00.275Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 92,
    "fields": {
      "question": 23,
      "value": "Abdominal Distension",
      "ordering": 6,
      "created_at": "2018-01-12T18:08:00.276Z"
    }
  },
  {
    "model": "reports.representation",
    "pk": 21,
    "fields": {
      "type": "type_multiselect_top",
      "question": 23,
      "active": true,
      "ordering": 7,
      "label1": "Label1",
      "label2": "Label2",
      "label3": "Label3"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 6,
    "fields": {
      "question": 22,
      "lang": 1,
      "text": "Was sind die drei wichtigsten Gr\u00fcnde daf\u00fcr, dass Sie einen Patienten auf Tolvaptan beginnen?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 25,
    "fields": {
      "question": 22,
      "lang": 2,
      "text": "\u00bfCu\u00e1les son las tres razones principales que lo har\u00e1n comenzar un paciente con Tolvaptan?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 26,
    "fields": {
      "question": 22,
      "lang": 3,
      "text": "Quelles sont les trois principales raisons qui vous inciteraient \u00e0 commencer un patient sous Tolvaptan?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 27,
    "fields": {
      "question": 22,
      "lang": 4,
      "text": "Quali sono i tre principali motivi che potrebbero farti iniziare un paziente con Tolvaptan?"
    }
  },
  {
    "model": "survey.option",
    "pk": 79,
    "fields": {
      "question": 22,
      "value": "Age",
      "ordering": 1,
      "created_at": "2018-01-12T18:03:45.623Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 80,
    "fields": {
      "question": 22,
      "value": "CKD Stage",
      "ordering": 2,
      "created_at": "2018-01-12T18:03:45.647Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 81,
    "fields": {
      "question": 22,
      "value": "Renal Volume",
      "ordering": 3,
      "created_at": "2018-01-12T18:03:45.649Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 82,
    "fields": {
      "question": 22,
      "value": "EGFR decline",
      "ordering": 4,
      "created_at": "2018-01-12T18:03:45.650Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 83,
    "fields": {
      "question": 22,
      "value": "Patient request",
      "ordering": 5,
      "created_at": "2018-01-12T18:03:45.651Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 84,
    "fields": {
      "question": 22,
      "value": "Family history",
      "ordering": 6,
      "created_at": "2018-01-12T18:03:45.652Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 85,
    "fields": {
      "question": 22,
      "value": "Symptoms",
      "ordering": 7,
      "created_at": "2018-01-12T18:03:45.654Z"
    }
  },
  {
    "model": "survey.option",
    "pk": 86,
    "fields": {
      "question": 22,
      "value": "Truncating mutation",
      "ordering": 8,
      "created_at": "2018-01-12T18:03:45.656Z"
    }
  },
  {
    "model": "reports.representation",
    "pk": 20,
    "fields": {
      "type": "type_multiselect_top",
      "question": 22,
      "active": true,
      "ordering": 6,
      "label1": "Label1",
      "label2": "Label2",
      "label3": "Label3"
    }
  },
  {
    "model": "survey.question",
    "pk": 25,
    "fields": {
      "survey": 9,
      "ordering": 9,
      "type": "type_yes_no",
      "field": null,
      "text": "If you have a database, do you include the fast progressor criteria?",
      "depends_on": null,
      "available_if": "",
      "dependency_type": null,
      "script": "",
      "created_at": "2018-01-12T18:12:46.713Z"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 9,
    "fields": {
      "question": 25,
      "lang": 1,
      "text": "Wenn Sie eine Datenbank haben, f\u00fcgen Sie die schnellen Fortschrittskriterien hinzu?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 34,
    "fields": {
      "question": 25,
      "lang": 2,
      "text": "Si tiene una base de datos, \u00bfincluye los criterios r\u00e1pidos de progressor?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 35,
    "fields": {
      "question": 25,
      "lang": 3,
      "text": "Si vous avez une base de donn\u00e9es, incluez-vous les crit\u00e8res de progression rapide?"
    }
  },
  {
    "model": "survey.questiontranslation",
    "pk": 36,
    "fields": {
      "question": 25,
      "lang": 4,
      "text": "Se si dispone di un database, si includono i criteri di avanzamento rapido?"
    }
  },
  {
    "model": "reports.representation",
    "pk": 23,
    "fields": {
      "type": "type_yes_no",
      "question": 25,
      "active": true,
      "ordering": 9,
      "label1": "",
      "label2": "",
      "label3": ""
    }
  }
]
